{
  "docId": "019dd923-622c-750b-8b9b-a077f08347fa",
  "docSlug": "4934d687cb38",
  "documentTitle": "Valeant Pharmaceuticals International (VRX)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2015-10-30 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 17,
  "pageCount": 39,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": null,
  "function": null,
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "Image file at /tmp/legacy-images/4934d687cb38/slides/017.jpg does not exist on disk; unable to inspect contents.",
  "elementsJson": null,
  "metadataConfidence": 0,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-a077f08347fa/17",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa#slide-17",
  "components": [],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 21,
      "from": 17,
      "beatId": "f826f826-9857-48f7-81f2-57a1bd4e0426",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Preempt Rebuttal",
      "beatSlug": null,
      "evidence": "Addressing potential criticisms and rebuttals",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}